Cellectis SA (0WA2) Share Forecast & Price Target
0WA2 Analyst Ratings
There are no analyst ratings in the last 3 months.
0WA2 Stock 12 Month Forecast
There are no analyst price targets in the last 3 months.
Detailed List of Analyst Forecasts
| Analyst Profile | Expert Firm | Price Target | Position | Upside / Downside | Action | Date | Follow | Article |
|---|---|---|---|---|---|---|---|---|
| PerPlexity - SonarReasoningPro | TipRanks - PerPlexity | EUR 0.89→EUR 1 | sell | -4.49%Downside | Reiterated | 10/29/26 | ||
| Google Biotechnology | TipRanks - Google | EUR 0.88→EUR 1 | sell | -4.49%Downside | Reiterated | 10/29/26 | ||
| Anthropic Biotechnology | TipRanks - Anthropic | EUR 0.85→EUR 1 | sell | -4.49%Downside | Reiterated | 10/29/26 | ||
| OpenAI - Gpt-5.6Sol | TipRanks - OpenAI | EUR 0.90→EUR 1 | hold | -4.49%Downside | Reiterated | 10/29/26 | ||
| DeepSeek - V4Pro | TipRanks - DeepSeek | EUR 0.88→EUR 1 | sell | -4.49%Downside | Reiterated | 10/29/26 | ||
| xAI - Grok-4.3 | TipRanks - xAI | EUR 0.88→EUR 1 | sell | -4.49%Downside | Reiterated | 10/29/26 |
| Analyst Profile | Date | Price Target | Position | Upside / Downside | Action | Follow | Article | Expert Firm |
|---|---|---|---|---|---|---|---|---|
| PerPlexity - SonarReasoningPro | 10/29/26 | EUR 0.89→EUR 1 | sell | -4.49%Downside | Reiterated | TipRanks - PerPlexity | ||
| Google Biotechnology | 10/29/26 | EUR 0.88→EUR 1 | sell | -4.49%Downside | Reiterated | TipRanks - Google | ||
| Anthropic Biotechnology | 10/29/26 | EUR 0.85→EUR 1 | sell | -4.49%Downside | Reiterated | TipRanks - Anthropic | ||
| OpenAI - Gpt-5.6Sol | 10/29/26 | EUR 0.90→EUR 1 | hold | -4.49%Downside | Reiterated | TipRanks - OpenAI | ||
| DeepSeek - V4Pro | 10/29/26 | EUR 0.88→EUR 1 | sell | -4.49%Downside | Reiterated | TipRanks - DeepSeek | ||
| xAI - Grok-4.3 | 10/29/26 | EUR 0.88→EUR 1 | sell | -4.49%Downside | Reiterated | TipRanks - xAI |
Best Analysts Covering Cellectis SA
Copying Google Biotechnology's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +35.70% per trade.
Copying Google Biotechnology's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +35.70% per trade.
Copying Google Biotechnology's trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of +35.70% per trade.
0WA2 Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 0 | 0 | 0 |
In the current month, 0WA2 has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 0WA2 average Analyst price target in the past 3 months is ―.
0WA2 Financial Forecast
0WA2 Earnings Forecast
Next quarter’s earnings estimate for 0WA2 is -EUR 0.16 with a range of -EUR 0.20 to -EUR 0.06. The previous quarter’s EPS was -EUR 0.19. 0WA2 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 0WA2 has Performed in-line its overall industry.
0WA2 Sales Forecast
Next quarter’s sales forecast for 0WA2 is EUR 13.51M with a range of EUR 8.67M to EUR 16.88M. The previous quarter’s sales results were EUR 4.50M. 0WA2 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 0WA2 has Performed in-line its overall industry.